Alimera Sciences Inc
ALIMDelisted Sep 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267602
Alimera Sciences Inc was delisted on Sep 16, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 52 institutions reported holding it in 13F filings for Q2 2024, worth $257.9M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Alimera Sciences Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −6 vs. Q2 2022
- Shares held
- 1.72M
- +72.2K (+4.4%) vs. Q2 2022
- Total value
- $8.73M
- −$276.0K (−3.1%) vs. Q2 2022
- New holders
- 0
- 5 more added
- Sold out
- 6
- 4 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 52 | $257.9M |
| Q1 2024 | 39 | $186.9M |
| Q4 2023 | 35 | $208.4M |
| Q3 2023 | 30 | $146.5M |
| Q2 2023 | 18 | $10.3M |
| Q1 2023 | 16 | $4.30M |
| Q4 2022 | 20 | $6.13M |
| Q3 2022 | 14 | $8.73M |
| Q2 2022 | 20 | $9.00M |
| Q1 2022 | 18 | $8.49M |
| Q4 2021 | 21 | $9.09M |
| Q3 2021 | 27 | $8.29M |
| Q2 2021 | 25 | $17.9M |
| Q1 2021 | 25 | $18.1M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Alimera Sciences Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 669,546 | $3.40M | 0.00% | +106,222+18.9% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 250,000 | $1.27M | 0.01% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 227,602 | $1.16M | 1.35% | +40,601+21.7% | Added |
| Palo Alto Investors LP | 200,919 | $1.02M | 0.08% | 00.0% | Unchanged |
| Vanguard Group Inc | 148,566 | $755.0K | 0.00% | −793−0.5% | Reduced |
| Renaissance Technologies LLC | 112,694 | $572.0K | 0.00% | −14,999−11.7% | Reduced |
| Geode Capital Management, LLC | 38,320 | $194.0K | 0.00% | +12,002+45.6% | Added |
| Acadian Asset Management LLC | 19,542 | $98.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 18,300 | $93.0K | 0.00% | 00.0% | Unchanged |
| Perritt Capital Management Inc | 18,000 | $91.0K | 0.06% | −9,400−34.3% | Reduced |
| BlackRock Inc. | 12,870 | $65.0K | 0.00% | −13,128−50.5% | Reduced |
| Tower Research Capital LLC (TRC) | 1,982 | $10.0K | 0.00% | +826+71.5% | Added |
| Wells Fargo & Company | 37 | $0 | 0.00% | +7+23.3% | Added |
| Focused Wealth Management, Inc | 66 | $0 | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 0 | $0 | 0.00% | −28,052−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −14,402−100.0% | Sold out |
| Optimum Investment Advisors | 0 | $0 | 0.00% | −4,108−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2,198−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −333−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −7−100.0% | Sold out |